For research use only. Not for therapeutic Use.
Desethyl Azilsartan Medoxomil(CAT: C000620) is an impurity that arises during the synthesis of Azilsartan Medoxomil, a pharmaceutical compound used to treat hypertension. This impurity is a byproduct of the synthesis process and is essential to monitor and control during the manufacturing of Azilsartan Medoxomil to ensure the final product’s purity and safety.
| CAS Number | 1417576-00-1 |
| Synonyms | 3-[[2′-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1′-biphenyl]-4-yl]methyl]-2,3-dihydro-2-oxo-1H-benzimidazole-4-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester |
| Molecular Formula | C₂₈H₂₀N₄O₈ |
| Purity | ≥95% |
| Solubility | DMSO (Slightly), Methanol (Slightly, Heated) |
| Appearance | White to Off-White Solid |
| Storage | -20°C, Inert atmosphere |
| Reference | Radl, S., et al.: Org. Process. Res. Dev., 17), 77-86 (2013); Baker, W. & White, W.: Pharmacotherapy, 45, 1506 (2011); Cushman, W., et al.: Hypertension, 60, 310 (2012); Lastra, G., et al.: Cardio. Med. 3, 154 (2013); Miura, S., et al.: Hypertens. Res., 36, 134 (2012); Rakugi, H., et al.: Hypertens. Res., 35, 552 (2012) |
